Patient and Caregiver Treatment Preferences in Type 2 and Non-ambulatory Type 3 Spinal Muscular Atrophy: A Discrete Choice Experiment Survey in Five European Countries
Lo, SH., Lawrence, C., Gorni, K., Sutherland, CS., Marti, Y., Lloyd, AJ., Paracha, N. (2022). Preferences and Utilities for Treatment Attributes in Type 2 and Non-ambulatory Type 3 Spinal Muscular Atrophy in the United Kingdom. Pharmacoeconomics, 40, 91-102.
Read More